Save €19.99Tesamorelin + Retatrutide Stack
Dual-compound stack combining GHRH analog with triple receptor agonist.
Description
A powerful research combination pairing Tesamorelin (2mg) with Retatrutide (5mg) for comprehensive metabolic research. This stack combines Tesamorelin's targeted visceral fat reduction through GH-axis activation with Retatrutide's triple receptor agonism (GLP-1/GIP/Glucagon), providing researchers with a multi-pathway approach to metabolic modulation.
The complementary mechanisms allow for simultaneous study of GH-mediated lipolysis and incretin-based appetite/glucose regulation. This combination is popular in advanced body composition research protocols. Both compounds are for research purposes only.
Related Products
Retatrutide
Triple GLP-1/GIP/Glucagon receptor agonist for next-gen metabolic research.
Tesamorelin
FDA-studied GHRH analog for visceral fat reduction and GH optimization research.
Bacteriostatic Water (BAC Water)
Sterile bacteriostatic water for safe peptide reconstitution and research use.